Novavax, Inc. (NVAX)
USD 6.17
(-1.12%)
USD 6.17
(-1.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 639.93 Million USD | 1.14% |
| 2022 | 696.31 Million USD | -38.58% |
| 2021 | 1.13 Billion USD | 517.65% |
| 2020 | -271.42 Million USD | -185.17% |
| 2019 | -95.18 Million USD | -377.59% |
| 2018 | 34.28 Million USD | 9.98% |
| 2017 | 31.17 Million USD | 114.01% |
| 2016 | -222.58 Million USD | -76.1% |
| 2015 | -126.39 Million USD | -906.5% |
| 2014 | 15.67 Million USD | 23.47% |
| 2013 | 12.69 Million USD | 71.9% |
| 2012 | 7.38 Million USD | -3.92% |
| 2011 | 7.68 Million USD | 2140.52% |
| 2010 | 343 Thousand USD | 5.54% |
| 2009 | 325 Thousand USD | -69.45% |
| 2008 | 1.06 Million USD | -17.65% |
| 2007 | 1.29 Million USD | 172.18% |
| 2006 | -1.79 Million USD | -212.09% |
| 2005 | 1.59 Million USD | -66.52% |
| 2004 | 4.77 Million USD | -50.97% |
| 2003 | 9.72 Million USD | -15.01% |
| 2002 | 11.44 Million USD | -42.81% |
| 2001 | 20.01 Million USD | 552.13% |
| 2000 | 3.06 Million USD | 91.81% |
| 1999 | 1.6 Million USD | 60.0% |
| 1998 | 1 Million USD | 25.0% |
| 1997 | 800 Thousand USD | 100.0% |
| 1996 | 400 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 379.44 Million USD | 742.34% |
| 2024 Q1 | 45.04 Million USD | -68.38% |
| 2023 FY | 704.23 Million USD | 1.14% |
| 2023 Q3 | -76.86 Million USD | -120.85% |
| 2023 Q2 | 368.64 Million USD | 686.62% |
| 2023 Q1 | 46.86 Million USD | -55.81% |
| 2023 Q4 | 142.46 Million USD | 285.35% |
| 2022 Q3 | 299.98 Million USD | 452.29% |
| 2022 Q4 | 106.06 Million USD | -64.64% |
| 2022 Q1 | 688.76 Million USD | 215.18% |
| 2022 FY | 696.31 Million USD | -38.58% |
| 2022 Q2 | -85.15 Million USD | -112.36% |
| 2021 FY | 1.13 Billion USD | 517.65% |
| 2021 Q2 | 298.01 Million USD | -33.36% |
| 2021 Q1 | 447.22 Million USD | 59.92% |
| 2021 Q3 | 178.84 Million USD | -39.99% |
| 2021 Q4 | 218.52 Million USD | 22.19% |
| 2020 Q3 | 157.02 Million USD | 341.85% |
| 2020 Q2 | 35.53 Million USD | 952.35% |
| 2020 FY | -271.42 Million USD | -185.17% |
| 2020 Q1 | 3.37 Million USD | -61.69% |
| 2020 Q4 | 279.65 Million USD | 78.1% |
| 2019 Q4 | 8.81 Million USD | 251.66% |
| 2019 FY | -95.18 Million USD | -377.59% |
| 2019 Q3 | 2.5 Million USD | -25.32% |
| 2019 Q1 | 3.98 Million USD | -35.01% |
| 2019 Q2 | 3.35 Million USD | -15.7% |
| 2018 Q1 | 9.65 Million USD | 124.6% |
| 2018 FY | 34.28 Million USD | 9.98% |
| 2018 Q3 | 7.73 Million USD | -28.2% |
| 2018 Q2 | 10.77 Million USD | 11.6% |
| 2018 Q4 | 6.12 Million USD | -20.79% |
| 2017 FY | 31.17 Million USD | 114.01% |
| 2017 Q2 | 6.73 Million USD | 18.52% |
| 2017 Q3 | 8.35 Million USD | 24.06% |
| 2017 Q4 | -39.24 Million USD | -569.88% |
| 2017 Q1 | 5.68 Million USD | 112.43% |
| 2016 Q3 | 3.23 Million USD | 28.98% |
| 2016 FY | -222.58 Million USD | -76.1% |
| 2016 Q2 | 2.5 Million USD | -40.61% |
| 2016 Q4 | -45.7 Million USD | -1514.45% |
| 2016 Q1 | 4.21 Million USD | 306.76% |
| 2015 Q3 | 3.77 Million USD | -66.59% |
| 2015 Q4 | -2.04 Million USD | -154.0% |
| 2015 Q2 | 11.3 Million USD | 52.45% |
| 2015 Q1 | 7.41 Million USD | 90.84% |
| 2015 FY | -126.39 Million USD | -906.5% |
| 2014 Q3 | 4.18 Million USD | 32.63% |
| 2014 FY | 15.67 Million USD | 23.47% |
| 2014 Q2 | 3.15 Million USD | -28.91% |
| 2014 Q1 | 4.44 Million USD | -27.73% |
| 2014 Q4 | 3.88 Million USD | -7.17% |
| 2013 Q2 | 1.89 Million USD | -10.47% |
| 2013 Q1 | 2.12 Million USD | -18.86% |
| 2013 FY | 12.69 Million USD | 71.9% |
| 2013 Q4 | 6.14 Million USD | 143.27% |
| 2013 Q3 | 2.52 Million USD | 33.02% |
| 2012 FY | 7.38 Million USD | -3.92% |
| 2012 Q2 | 1.98 Million USD | 131.89% |
| 2012 Q3 | 1.92 Million USD | -2.92% |
| 2012 Q4 | 2.61 Million USD | 35.65% |
| 2012 Q1 | 856 Thousand USD | 173.92% |
| 2011 Q4 | -1.15 Million USD | -123.12% |
| 2011 FY | 7.68 Million USD | 2140.52% |
| 2011 Q1 | 834 Thousand USD | 1535.29% |
| 2011 Q2 | 3 Million USD | 259.83% |
| 2011 Q3 | 5 Million USD | 66.88% |
| 2010 FY | 343 Thousand USD | 5.54% |
| 2010 Q2 | 7000.00 USD | -93.64% |
| 2010 Q1 | 110 Thousand USD | 48.65% |
| 2010 Q4 | 51 Thousand USD | -70.86% |
| 2010 Q3 | 175 Thousand USD | 2400.0% |
| 2009 Q3 | 201 Thousand USD | 593.1% |
| 2009 FY | 325 Thousand USD | -69.45% |
| 2009 Q2 | 29 Thousand USD | 38.1% |
| 2009 Q4 | 74 Thousand USD | -63.18% |
| 2009 Q1 | 21 Thousand USD | -70.0% |
| 2008 Q1 | 458 Thousand USD | -81.07% |
| 2008 FY | 1.06 Million USD | -17.65% |
| 2008 Q4 | 70 Thousand USD | -63.92% |
| 2008 Q3 | 194 Thousand USD | -43.27% |
| 2008 Q2 | 342 Thousand USD | -25.33% |
| 2007 Q1 | -736 Thousand USD | 52.85% |
| 2007 Q4 | 2.41 Million USD | 1004.57% |
| 2007 FY | 1.29 Million USD | 172.18% |
| 2007 Q3 | 219 Thousand USD | 131.42% |
| 2007 Q2 | -697 Thousand USD | 5.3% |
| 2006 Q1 | -245 Thousand USD | -116.04% |
| 2006 Q3 | 23 Thousand USD | 107.14% |
| 2006 Q2 | -322 Thousand USD | -31.43% |
| 2006 FY | -1.79 Million USD | -212.09% |
| 2006 Q4 | -1.56 Million USD | -6886.96% |
| 2005 Q4 | 1.52 Million USD | 91.11% |
| 2005 Q1 | -1.01 Million USD | -248.68% |
| 2005 Q2 | 288 Thousand USD | 128.32% |
| 2005 Q3 | 799 Thousand USD | 177.43% |
| 2005 FY | 1.59 Million USD | -66.52% |
| 2004 FY | 4.77 Million USD | -50.97% |
| 2004 Q1 | 2.95 Million USD | -12.39% |
| 2004 Q2 | 1.5 Million USD | -49.14% |
| 2004 Q3 | 289 Thousand USD | -80.78% |
| 2004 Q4 | 684 Thousand USD | 136.68% |
| 2003 Q4 | 3.37 Million USD | -3.79% |
| 2003 Q3 | 3.5 Million USD | 85.9% |
| 2003 Q1 | 960 Thousand USD | -0.83% |
| 2003 Q2 | 1.88 Million USD | 96.56% |
| 2003 FY | 9.72 Million USD | -15.01% |
| 2002 FY | 11.44 Million USD | -42.81% |
| 2002 Q4 | 968 Thousand USD | -43.23% |
| 2002 Q3 | 1.7 Million USD | -54.38% |
| 2002 Q2 | 3.73 Million USD | -25.81% |
| 2002 Q1 | 5.03 Million USD | 0.92% |
| 2001 Q2 | 6.88 Million USD | 75.48% |
| 2001 Q3 | 4.21 Million USD | -38.76% |
| 2001 Q4 | 4.99 Million USD | 18.38% |
| 2001 FY | 20.01 Million USD | 552.13% |
| 2001 Q1 | 3.92 Million USD | 259.25% |
| 2000 Q3 | 473 Thousand USD | -31.65% |
| 2000 Q2 | 692 Thousand USD | -14.78% |
| 2000 Q1 | 812 Thousand USD | 1.5% |
| 2000 FY | 3.06 Million USD | 91.81% |
| 2000 Q4 | 1.09 Million USD | 130.87% |
| 1999 Q3 | 300 Thousand USD | 0.0% |
| 1999 Q2 | 300 Thousand USD | 50.0% |
| 1999 FY | 1.6 Million USD | 60.0% |
| 1999 Q1 | 200 Thousand USD | -33.33% |
| 1999 Q4 | 800 Thousand USD | 166.67% |
| 1998 Q2 | 200 Thousand USD | -33.33% |
| 1998 Q1 | 300 Thousand USD | -25.0% |
| 1998 FY | 1 Million USD | 25.0% |
| 1998 Q3 | 200 Thousand USD | 0.0% |
| 1998 Q4 | 300 Thousand USD | 50.0% |
| 1997 Q4 | 400 Thousand USD | 100.0% |
| 1997 Q3 | 200 Thousand USD | 100.0% |
| 1997 Q1 | 200 Thousand USD | 100.0% |
| 1997 Q2 | 100 Thousand USD | -50.0% |
| 1997 FY | 800 Thousand USD | 100.0% |
| 1996 Q2 | 200 Thousand USD | 0.0% |
| 1996 FY | 400 Thousand USD | 0.0% |
| 1996 Q3 | 200 Thousand USD | 0.0% |
| 1996 Q1 | 200 Thousand USD | 0.0% |
| 1996 Q4 | 100 Thousand USD | -50.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -1582.938% |
| Alkermes plc | 1.37 Billion USD | 53.448% |
| Agenus Inc. | 139.61 Million USD | -358.358% |
| Aptorum Group Limited | -1.11 Million USD | 57509.517% |
| Ardelyx, Inc. | 106.66 Million USD | -499.973% |
| Dyadic International, Inc. | 922.95 Thousand USD | -69235.516% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -2938.493% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 366106.646% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 4890.719% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 1466.248% |
| Pyxis Oncology, Inc. | -2 Million USD | 32096.85% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 123939.759% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -3260.484% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 1448314.447% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 121530.171% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 751.554% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -79692.643% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 780510.976% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -373.085% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -8030.314% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 760.069% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 57.84% |
| AlloVir, Inc. | -398 Thousand USD | 160888.191% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -165.826% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -150828.538% |
| Bicycle Therapeutics plc | -129.52 Million USD | 594.084% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -533180.833% |
| ChromaDex Corporation | 50.78 Million USD | -1160.215% |
| Chimerix, Inc. | 324 Thousand USD | -197411.42% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 2153.208% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 924.682% |
| CRISPR Therapeutics AG | 240.95 Million USD | -165.583% |
| Precision BioSciences, Inc. | 40.47 Million USD | -1481.185% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 751.913% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1006.143% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1006.143% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -3760.391% |
| ImmuCell Corporation | 4.39 Million USD | -14456.316% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 703.014% |
| Immix Biopharma, Inc. | -5468.00 USD | 11703410.168% |
| Incyte Corporation | 3.44 Billion USD | 81.401% |
| Innoviva, Inc. | 261.06 Million USD | -145.126% |
| IO Biotech, Inc. | -756 Thousand USD | 84747.751% |
| Jaguar Health, Inc. | 7.72 Million USD | -8185.047% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 96476.054% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -434.381% |
| ContextLogic Inc. | 59 Million USD | -984.639% |
| MiMedx Group, Inc. | 266.84 Million USD | -139.818% |
| MEI Pharma, Inc. | 49.32 Million USD | -1197.336% |
| NextCure, Inc. | -3.68 Million USD | 17470.711% |
| Onconetix, Inc. | -1.12 Million USD | 56874.03% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 2309.117% |
| Opthea Limited | 21.72 Thousand USD | -2946202.947% |
| Psyence Biomedical Ltd. | -240.00 USD | 266640516.667% |
| Vaxcyte, Inc. | -75 Million USD | 953.249% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 1116411.97% |
| Precigen, Inc. | 106 Thousand USD | -603614.151% |
| Pharming Group N.V. | 220.1 Million USD | -190.743% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -124159.612% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -63322.894% |
| PureTech Health plc | -1.6 Million USD | 40021.21% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -482.969% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 452.761% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 1511.885% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 3010.524% |
| Acelyrin, Inc. | -115 Thousand USD | 556566.957% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 6366998.816% |
| Summit Therapeutics Inc. | -2.05 Million USD | 31316.439% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 112173.03% |
| Senti Biosciences, Inc. | -2.68 Million USD | 23951.547% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -15697.013% |
| Elevation Oncology, Inc. | -39 Thousand USD | 1640964.103% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 13437.578% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 16333.618% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -2096.907% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -128919.556% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 1163621.818% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -514.739% |
| Seer, Inc. | 7.02 Million USD | -9006.831% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -14517.108% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -2870.234% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 540172.242% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 446668.412% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -104979.967% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -431.183% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -104.015% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 12798840.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -24761.577% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 1261308.12% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -2077.619% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 275934.914% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 130168.496% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 9115.737% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 134952.754% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 6153340.385% |
| Soligenix, Inc. | 97.31 Thousand USD | -657520.413% |
| Century Therapeutics, Inc. | -10.8 Million USD | 6020.409% |
| Kura Oncology, Inc. | -849 Thousand USD | 75475.383% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 1053.65% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 435431.293% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -546.146% |
| Autolus Therapeutics plc | -4.86 Million USD | 13248.49% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -1446.264% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 381014.881% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -575.588% |
| GRI Bio, Inc. | 10.84 Million USD | -5802.933% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -25094.509% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 7466.605% |
| IGM Biosciences, Inc. | -211.66 Million USD | 402.342% |
| INmune Bio, Inc. | 155 Thousand USD | -412762.581% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -933.173% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 42584.288% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 98786.568% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 2186125.142% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -159088.308% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 32160.972% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 204552.716% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -577.462% |
| Verastem, Inc. | -62 Thousand USD | 1032256.452% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -26180.78% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 245286.59% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -21040.965% |
| Histogen Inc. | 3.76 Million USD | -16878.96% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -110965.658% |
| Surrozen, Inc. | -27.23 Million USD | 2450.118% |
| Organovo Holdings, Inc. | -5.38 Million USD | 11974.875% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 53212.094% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 2595.173% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -3091.387% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 32320150.505% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -10448.836% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 953366.002% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -313.42% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -438814.266% |
| Apollomics, Inc. | 127 Thousand USD | -503787.402% |
| Amarin Corporation plc | 165.54 Million USD | -286.573% |
| Mesoblast Limited | -9.81 Million USD | 6619.99% |
| Turnstone Biologics Corp. | 16.5 Million USD | -3776.996% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 679.186% |
| Synaptogenix, Inc. | -6347.00 USD | 10082611.423% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 1254878.431% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -296.577% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 63.592% |
| Better Therapeutics, Inc. | -2.72 Million USD | 23549.505% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 670.552% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -89.285% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 5609645.933% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 10322.636% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 57856.047% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -8644.697% |
| Insmed Incorporated | 239.63 Million USD | -167.047% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -17785.327% |
| OmniAb, Inc. | 14.66 Million USD | -4263.108% |
| Alector, Inc. | -95.05 Million USD | 773.242% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -409.419% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 1572.372% |
| Zai Lab Limited | 170.9 Million USD | -274.445% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -681.583% |
| Aura Biosciences, Inc. | -1.29 Million USD | 49515.985% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -492159.231% |
| Immunic, Inc. | -111 Thousand USD | 576619.82% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -3936.439% |
| Veracyte, Inc. | 248.14 Million USD | -157.885% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 109.156% |
| FibroGen, Inc. | 128.9 Million USD | -396.445% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 113464107.092% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 5585.072% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 81.171% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -164408.226% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -80.089% |
| TG Therapeutics, Inc. | 219.1 Million USD | -192.065% |
| Galecto, Inc. | -830 Thousand USD | 77200.843% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 46304.838% |
| Fortrea Holdings Inc. | 424 Million USD | -50.929% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 842.671% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 112963.668% |
| XBiotech Inc. | -1.74 Million USD | 36793.635% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 57856.047% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 1477.067% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 947.217% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -771.813% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -3708.469% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -64.491% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 1388.974% |
| Vaxxinity, Inc. | -2.23 Million USD | 28745.345% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -95.849% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 5751.236% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -2517.222% |
| NexImmune, Inc. | -1.02 Million USD | 62534.584% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -11850585.185% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 9106.023% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 94.338% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 957702.466% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 18121.318% |
| Ainos, Inc. | -253.73 Thousand USD | 252308.818% |
| Pluri Inc. | 322 Thousand USD | -198638.199% |
| Prothena Corporation plc | -129.2 Million USD | 595.303% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -1169.113% |
| Celularity Inc. | 6.75 Million USD | -9373.531% |
| Rallybio Corporation | -150 Thousand USD | 426724.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 2062.576% |
| MeiraGTx Holdings plc | 287 Thousand USD | -222874.564% |
| Omeros Corporation | -69.77 Million USD | 1017.091% |
| Humacyte, Inc. | -76.55 Million USD | 935.973% |
| Immunocore Holdings plc | 248.39 Million USD | -157.633% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 4318.716% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -925.836% |
| Blueprint Medicines Corporation | 236.58 Million USD | -170.49% |
| CalciMedica, Inc. | -58 Thousand USD | 1103439.655% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 44976.367% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -2102.502% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 22601.301% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 2173.342% |
| Pulmatrix, Inc. | -8.22 Million USD | 7885.122% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 54795.47% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 160485.213% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 260.468% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -22955.932% |
| Cytokinetics, Incorporated | -322.59 Million USD | 298.373% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -74129.589% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 187764.809% |
| Vor Biopharma Inc. | -3.49 Million USD | 18425.802% |
| Roivant Sciences Ltd. | 109.23 Million USD | -485.835% |
| Evogene Ltd. | 1.39 Million USD | -45642.459% |
| ProKidney Corp. | -3.16 Million USD | 20293.657% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 1557.317% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -9232.609% |
| CorMedix Inc. | -205.56 Thousand USD | 311410.943% |
| BioLineRx Ltd. | 1.1 Million USD | -57656.047% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 913.434% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 1939303.03% |
| Atai Life Sciences N.V. | -5000.00 USD | 12798840.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 525245.455% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 666701.042% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 46171.778% |
| Sagimet Biosciences Inc. | 2 Million USD | -31896.85% |
| MediciNova, Inc. | 979.7 Thousand USD | -65219.356% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 858.948% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 676888.113% |
| GeoVax Labs, Inc. | -20.72 Million USD | 3188.385% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -161.695% |
| Biomea Fusion, Inc. | -4.2 Million USD | 15332.968% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 26.641% |
| Mereo BioPharma Group plc | 7.42 Million USD | -8517.52% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 206531.29% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 5332908.333% |
| Absci Corporation | -41.84 Million USD | 1629.157% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 12798840.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 937.91% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 26103.129% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -199.407% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 68106.057% |
| Allakos Inc. | -6.14 Million USD | 10520.73% |
| Imunon, Inc. | -720 Thousand USD | 88979.522% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 1027.499% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -34.47% |
| BioAtla, Inc. | -103.73 Million USD | 716.92% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 5609645.933% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 359615.169% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 363.545% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 205867.524% |
| XOMA Corporation | 3.86 Million USD | -16474.385% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 1013.087% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -4225.652% |
| aTyr Pharma, Inc. | -2.38 Million USD | 26898.032% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -5035.931% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 2206779.31% |
| Viridian Therapeutics, Inc. | -1 Million USD | 63585.813% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -4922592207.692% |
| Akari Therapeutics, Plc | -4000.00 USD | 15998525.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -0.478% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -328564.975% |
| UroGen Pharma Ltd. | 73.35 Million USD | -772.419% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 2497.307% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -5511846.598% |
| Orgenesis Inc. | -5.72 Million USD | 11277.939% |
| Entera Bio Ltd. | -56 Thousand USD | 1142844.643% |
| GH Research PLC | -315 Thousand USD | 203254.603% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 338691.005% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 121992.762% |
| Xencor, Inc. | -85.26 Million USD | 850.571% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 289694.392% |
| Replimune Group, Inc. | -2.65 Million USD | 24203.089% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 64014.701% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -259.831% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -328564.975% |
| Portage Biotech Inc. | -54 Thousand USD | 1185168.519% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 676888.113% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 169844.562% |
| OncoCyte Corporation | 413 Thousand USD | -154848.426% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 14236740.712% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 288260009.91% |
| Purple Biotech Ltd. | -196 Thousand USD | 326598.469% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -7035.783% |
| scPharmaceuticals Inc. | 9.78 Million USD | -6441.985% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 6226.756% |
| HilleVax, Inc. | -2.15 Million USD | 29781.679% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 659828.866% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 4265209.304% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 95898.952% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 2782434.783% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 8525591.063% |
| Savara Inc. | -44.26 Million USD | 1545.793% |
| Curis, Inc. | 9.81 Million USD | -6422.648% |
| Daré Bioscience, Inc. | 2.76 Million USD | -23006.406% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 512919.342% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 37111.972% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 280774.123% |
| BeiGene, Ltd. | 2.07 Billion USD | 69.217% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 22988.408% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 260.119% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -1028.876% |
| Erasca, Inc. | -3.73 Million USD | 17247.294% |
| bluebird bio, Inc. | -4.03 Million USD | 15979.33% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 2267932.589% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 66.396% |
| DBV Technologies S.A. | 15.72 Million USD | -3968.775% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 2267932.589% |
| Moderna, Inc. | 2.15 Billion USD | 70.305% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 70038.47% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -7893.218% |
| Molecular Templates, Inc. | 50.39 Million USD | -1169.842% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 119491.231% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -378.322% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 10385.069% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 1726.559% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 675.856% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 17935.479% |
| MacroGenics, Inc. | 50.52 Million USD | -1166.525% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 10594.211% |
| Prime Medicine, Inc. | -147.9 Million USD | 532.668% |
| Aditxt, Inc. | -111.66 Thousand USD | 573212.126% |
| Adagene Inc. | 18.11 Million USD | -3433.32% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -131034.631% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -356.439% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -305.444% |
| SciSparc Ltd. | 2.19 Million USD | -29041.029% |
| Vericel Corporation | 135.57 Million USD | -372.013% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 2554840.708% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 2065612.233% |
| Generation Bio Co. | -73.91 Million USD | 965.821% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 146538.673% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -1071.638% |
| Invivyd, Inc. | -2.02 Million USD | 31655.079% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 312.716% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 618767.221% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -564.055% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -551.084% |
| ADMA Biologics, Inc. | 88.21 Million USD | -625.404% |
| Clene Inc. | 533 Thousand USD | -119963.227% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -2554.329% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 66969.07% |
| GeoVax Labs, Inc. | -20.72 Million USD | 3188.385% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -32089.99% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 329428.002% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -1184.885% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 9123.364% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 76647.488% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -667.173% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -875183.127% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -1103.749% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 469.504% |
| Trevena, Inc. | 1.45 Million USD | -43881.924% |
| Surrozen, Inc. | -27.23 Million USD | 2450.118% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 181385.269% |
| Cingulate Inc. | -582.91 Thousand USD | 109881.65% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 2064412.903% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 3348.576% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 8453693.131% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 72737.571% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 5.989% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 64870.951% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 1135908.101% |
| Kronos Bio, Inc. | 1.37 Million USD | -46542.638% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 1292.444% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 219256.507% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 131150.308% |
| ImmunityBio, Inc. | -17.89 Million USD | 3677.065% |
| Korro Bio, Inc. | -3.63 Million USD | 17729.118% |
| Kineta, Inc. | 5.43 Million USD | -11678.704% |
| BioVie Inc. | -229.37 Thousand USD | 279089.175% |
| Codexis, Inc. | 57.33 Million USD | -1016.156% |
| Celularity Inc. | 6.75 Million USD | -9373.531% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -15846.599% |
| Celcuity Inc. | -142.77 Thousand USD | 448323.041% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -1264847.618% |
| Cibus, Inc. | 1.42 Million USD | -44902.602% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 171206.15% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 2892.168% |
| IN8bio, Inc. | -2.5 Million USD | 25687.245% |
| Kodiak Sciences Inc. | -25.94 Million USD | 2566.324% |
| Annexon, Inc. | -3.26 Million USD | 19687.909% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 31408.072% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 1633.261% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -99890.156% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 17.8% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -270.002% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 33780.895% |
| Arcellx, Inc. | 108.27 Million USD | -491.007% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 2077.006% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -707.96% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 3125.421% |
| Moolec Science SA | -143.3 Thousand USD | 446655.947% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 1612.21% |
| Geron Corporation | -123.5 Million USD | 618.155% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -19368.725% |
| Royalty Pharma plc | 1.79 Billion USD | 64.327% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 1013.022% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 17717071.207% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -276460.886% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 674.378% |
| Humacyte, Inc. | -76.55 Million USD | 935.973% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 67520.41% |
| 89bio, Inc. | -273 Thousand USD | 234509.158% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 51009.865% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 75564.269% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 520373.984% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -57088.293% |
| Notable Labs, Ltd. | 113 Thousand USD | -566215.929% |
| Liquidia Corporation | 14.6 Million USD | -4283.13% |
| Mustang Bio, Inc. | -2.22 Million USD | 28861.213% |
| Immunovant, Inc. | -231 Thousand USD | 277129.004% |
| Quantum-Si incorporated | 488 Thousand USD | -131034.631% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 1251.815% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 2133223.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -34268.26% |
| Acasti Pharma Inc. | -11 Thousand USD | 5817709.091% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 312848.696% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 98786.568% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 482.025% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -56302.986% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 168062.467% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 32783.197% |
| PepGen Inc. | -1.18 Million USD | 54148.733% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 503987.402% |
| United Therapeutics Corporation | 2.07 Billion USD | 69.085% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 2894.851% |
| Solid Biosciences Inc. | -76.56 Million USD | 935.831% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 775001.614% |
| Immuneering Corporation | -764.13 Thousand USD | 83846.26% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -965638.561% |
| Belite Bio, Inc | -399 Thousand USD | 160485.213% |
| XOMA Corporation | 3.86 Million USD | -16474.385% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 3293.936% |
| Bionomics Limited | -434.44 Thousand USD | 147398.532% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 59684.451% |
| uniQure N.V. | 2.21 Million USD | -28791.061% |
| Cassava Sciences, Inc. | -89.42 Million USD | 815.629% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 795.062% |
| Forte Biosciences, Inc. | -9000.00 USD | 7110511.111% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 76739.162% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 146538.673% |
| Altimmune, Inc. | -65.37 Million USD | 1078.901% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -76.764% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 59684.451% |
| Compugen Ltd. | 31.45 Million USD | -1934.452% |
| Peak Bio, Inc. | 367.76 Thousand USD | -173905.15% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -2510.283% |
| Benitec Biopharma Inc. | 108 Thousand USD | -592434.259% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 820532.051% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 53295.096% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 35222.777% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 537862.185% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 53295.096% |
| Instil Bio, Inc. | -4.75 Million USD | 13555.362% |
| argenx SE | 1.1 Billion USD | 42.269% |
| Immunome, Inc. | -8.9 Million USD | 7284.653% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 33959.101% |
| Verona Pharma plc | -679.62 Thousand USD | 94260.448% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 365778.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | 26931.74% |
| CervoMed Inc. | -1.29 Million USD | 49568.433% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 26686.498% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 13496.211% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -25797.896% |
| Moolec Science SA | -143.3 Thousand USD | 446655.947% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 156935.772% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 24053.969% |
| AnaptysBio, Inc. | 14.78 Million USD | -4229.457% |
| Design Therapeutics, Inc. | -537 Thousand USD | 119268.901% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 149968.15% |
| NeurAxis, Inc. | 2.15 Million USD | -29571.99% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -29719.991% |
| Lumos Pharma, Inc. | 2 Million USD | -31785.252% |
| Achilles Therapeutics plc | -4.73 Million USD | 13625.7% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 365778.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 605670.854% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -1921.359% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -74129.589% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 62109.399% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 1504.973% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -1488125.581% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 77951.217% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 4863582.292% |
| Palisade Bio, Inc. | 246 Thousand USD | -260036.992% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 1939303.03% |
| Beam Therapeutics Inc. | -59.67 Million USD | 1172.424% |
| Neurogene Inc. | -3.26 Million USD | 19717.934% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -359.279% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 17433.072% |
| Sesen Bio, Inc. | 40 Million USD | -1499.843% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 215567.003% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 15991.014% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 6789.703% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -4445.007% |
| Athira Pharma, Inc. | -969 Thousand USD | 66140.97% |
| Vaccinex, Inc. | -16 Million USD | 4098.607% |
| HCW Biologics Inc. | -574.82 Thousand USD | 111427.467% |
| XOMA Corporation | 3.86 Million USD | -16474.385% |
| Nektar Therapeutics | 53.47 Million USD | -1096.636% |
| Arvinas, Inc. | 71.8 Million USD | -791.277% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 866.75% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 1119.414% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 198838.199% |
| Rezolute, Inc. | -36 Thousand USD | 1777702.778% |
| Clene Inc. | 533 Thousand USD | -119963.227% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 49839430.218% |
| BeyondSpring Inc. | 1.75 Million USD | -36446.945% |
| Synlogic, Inc. | -1.92 Million USD | 33360.759% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 1729659.459% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 10206.396% |
| Peak Bio, Inc. | 367.76 Thousand USD | -173905.15% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 3474.661% |
| Krystal Biotech, Inc. | 47.6 Million USD | -1244.264% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -353.563% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -12635.065% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 24815.445% |
| MannKind Corporation | 136.19 Million USD | -369.882% |
| Ikena Oncology, Inc. | -50.49 Million USD | 1367.403% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -488.102% |
| Gossamer Bio, Inc. | -4.38 Million USD | 14693.774% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 254043.254% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 12798840.0% |
| Legend Biotech Corporation | 140.92 Million USD | -354.085% |
| Mural Oncology plc | -2.56 Million USD | 25029.373% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 116241.016% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 640037.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -2983.439% |
| REGENXBIO Inc. | 53.02 Million USD | -1106.768% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 12045.914% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 332750.812% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 37047.864% |
| Vaxart, Inc. | -60.76 Million USD | 1153.169% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 243625.763% |
| Cellectis S.A. | 18 Thousand USD | -3555105.556% |
| Longeveron Inc. | 221 Thousand USD | -289464.253% |
| Repare Therapeutics Inc. | -80.07 Million USD | 899.222% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 41.451% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 49554.173% |
| Revolution Medicines, Inc. | -399.66 Million USD | 260.119% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 1828491.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -1305893.878% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 92.565% |
| Denali Therapeutics Inc. | -93.34 Million USD | 785.561% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 2554840.708% |
| Veru Inc. | 7.56 Million USD | -8358.143% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 423899.338% |
| Cingulate Inc. | -582.91 Thousand USD | 109881.65% |
| Passage Bio, Inc. | -3.72 Million USD | 17297.984% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 5313426.137% |
| Exicure, Inc. | -1.42 Million USD | 45070.977% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 167185.379% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -23575.065% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 124923.134% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -839.343% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 427845.36% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 1180.865% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -163566.752% |
| OmniAb, Inc. | 14.66 Million USD | -4263.108% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -3100.805% |
| Lipocine Inc. | -2.85 Million USD | 22547.487% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 34822.572% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 11317.125% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 42584.288% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -749.669% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 984618.462% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -659.155% |
| Ocugen, Inc. | -33.53 Million USD | 2008.152% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 20338.362% |
| Q32 Bio Inc. | 578 Thousand USD | -110615.744% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 241585.66% |
| Alumis Inc. Common Stock | -1.28 Million USD | 49939.33% |
| Equillium, Inc. | 35.95 Million USD | -1679.679% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 37588.987% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -127713.829% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 15479950.024% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 247179.923% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -151288.416% |
| Dominari Holdings Inc. | 2.03 Million USD | -31284.846% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 348894.632% |
| vTv Therapeutics Inc. | -13.59 Million USD | 4807.15% |
| Bio-Techne Corporation | 773.07 Million USD | 17.222% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -3595.0% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -38.879% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 54842.258% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 2768.628% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -5370.95% |
| Nkarta, Inc. | -5.86 Million USD | 11003.68% |
| BioCardia, Inc. | -7.24 Million USD | 8927.935% |
| Iterum Therapeutics plc | -1.75 Million USD | 36667.829% |